Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG

Ramelteon or Placebo

Ramelteon 16 mg, tablet, orally, once daily for Periods 1 or 2 and ramelteon placebo-matching tablets, orally, once daily for Periods 1 or 2.

Trial Locations (5)

Birmingham

Palm Springs

Santa Monica

Winter Park

Cincinnati